Lux Capital's Biotechnology Portfolio

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

H1 is on a mission to connect the world to the right doctor

Optimizing cell therapy with spatial biology

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Until Labs is advancing technology to pause biological time, with a dedicated in-house team of biologists, engineers, and physicists.

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design.

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

NILO Therapeutics is a biotechnology and therapeutics company.

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Kingdom creates and sells natural functional ingredients that actually work.

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Capella Bioscience engages in the discovery and development of monoclonal antibodies.

Tempo Pharmaceuticals is a biotechnology company based in Madrid, Spain.